Animal health professionals

  • Email
  • Help

Information for you

On this page, you will find information on the Agency’s activities, including news and events, that are most relevant to Animal health professionals and users of veterinary medicines such as pet owners.

You can contribute to the Agency’s work by responding to public consultations

Learn more about the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) and its role regarding medicines for veterinary use.

Featured information

  • EMA 2017 annual report

    EMA has published its 2017 annual report, which provides an overview of the work of the Agency together with the European medicines regulatory network. It highlights last year’s major achievements in protecting and promoting public and animal health in the European Union and contains key figures on the Agency’s regulatory procedures and activities.

  • Veterinary pharmacovigilance bulletin 2017

    EMA’s annual bulletin on veterinary pharmacovigilance provides information on the main outcome of post-marketing surveillance activities for veterinary medicines. The bulletin summarises recommendations to amend the safety warnings and highlights ongoing monitoring of several centrally authorised products. The latest bulletin hihglights that in 2017, the electronic reporting of adverse events to EudraVigilance Veterinary (EVVet) increased by near 25%.

  • veterinary_leaflet

    Healthy animals, healthy people

    EMA’s leaflet shows how the Agency promotes safe and effective veterinary therapies. The leaflet highlights the connection between animals and people’s health on topics like antimicrobial resistance or consumers’ safety.

  • New technologies, new types of medicines and therapies

    EMA’s Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT) provides guidance on development and authorisation of novel therapies. The group published, for the first time, specific guidance on monoclonal antibodies  in December 2017.

  • Antimicrobial resistance

    The Agency supports global efforts to combat antimicrobial resistance through the collection of data on the use of antimicrobials in the veterinary sector in the European Union. EMA also provides guidance on prudent use of antimicrobials in animals to limit the development of resistant bacteria.

News for animal health professionals

Events of interest

  • 19/04/2018


    European Medicines Agency veterinary medicines innovation day

    The purpose of the European Medicines Agency (EMA) veterinary medicines innovation day is to raise awareness and promote the support and measures that the Agency has to offer in the area of veterinary medicines innovation. The event is aimed at industry, including micro, small and medium-sized enterprises (SMEs) and veterinary consultants. The information provided will also be beneficial to academia, veterinary healthcare professionals and national competent authorities. ... Read more

  • 28/02/2018


    Extraordinary Management Board meeting: 28 February 2018

    This extraordinary Management Board meeting is to consider the building approval process for EMA’s premises in Amsterdam. The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency’s performance. ... Read more

  • 20/02/2018


    Substance, product, organisation and referential data (SPOR) impact on veterinary stakeholders

    The European Medicines Agency (EMA) held a webinar with veterinary medicines stakeholders, comprising national competent authorities and industry associations, to raise awareness of substance, product, organisation and referential (SPOR) data services and identify challenges related to the implementation of the SPOR programme. ... Read more

  • 22/06/2017 - 23/06/2017


    Focus group with invited stakeholders on field efficacy trials in the context of an EU authorisation for veterinary vaccines

    The Agency organised a focus group meeting with invited stakeholders on field efficacy trials in the context of an EU authorisation for veterinary vaccines. The scope of the meeting was to explore the specific challenges faced by industry in performing field trials to support efficacy claims in the context of an EU authorisation for veterinary vaccines and how these challenges might be overcome whilst still obtaining adequate assurances of the expected efficacy of a vaccine under field conditions. The focus group meeting was within the scope of the HMA Network Strategy on availability for veterinary vaccines that aims to increase their availability by ensuring efficient and effective cooperation between all stakeholders. ... Read more

  • 23/11/2016


    Focus group on promotion of pharmacovigilance for food producing animals

    This ad-hoc focus group meeting convened veterinary pharmacovigilance regulators, PhVWP-V interested parties and practising veterinarians to consider and develop aspects for encouraging reporting adverse events on food producing animals and providing feedback to reporters. The meeting aimed to provide a forum for open discussion and exchange of experiences to identify the challenges faced by veterinarians in relation to reporting post-authorisation issues and to explore ways in which to address these. This meeting was also an initial step at improving liaison between the veterinary pharmacovigilance network and representatives of the practising veterinary profession specialised in food-producing animals. ... Read more

  • See all Events of interest

Information for:

Find information for...

Antimicrobial resistance infographic